ALR Technologies SG Ltd. (ALRTF)
OTC Markets OTCPK
Price as at 30 Sept 2026, 16:15 UTC. Quotes are delayed.
Fundamentals
Valuation and ratings
ALR Technologies SG Ltd. trades at $0.02. We do not hold enough of the inputs to value this company with the confidence the estimate implies, so we publish no fair value for it rather than a number we would not defend.
About ALR Technologies SG Ltd.
ALR Technologies SG Ltd., a data management company, provides diabetes care management solutions. It offers ALRT Diabetes Solution, a diabetes care that includes a diabetes management system that collects data directly from blood glucose meters and continuous glucose monitoring devices, and Predictive A1C algorithm to track treatment success between lab reports and an FDA-cleared Insulin Dosing Adjustment program. The company also provides GluCurve Pet CGM, a solution to address an unmet need in diabetes care for felines and canines by combining the hardware of a CGM with the software of an adapted version of diabetes solution product for use by veterinarians in animal health. In addition, it offers healthcare services, including medical clinics, hospitals, and health plans, and veterinary clinics with diabetics being the initial patient targets. The company sells its products directly and through distributors in the United States, Brazil, the United Kingdom, European Union, and internationally. The company was incorporated in 1987 and is based in Singapore.
Company profile, industry and headcount are as reported by our data provider and can lag a company's own filings by a reporting period. The annual report is the authority.
Common questions
Where does SteadyShares get its ALRTF data?
Fundamentals for ALRTF come from company filings and exchange data, as listed on OTC Markets OTCPK; institutional ownership comes from SEC 13F filings. The share price shown was last refreshed on 30 Sept 2026, 16:15 UTC and is delayed. Metrics we do not hold are left out of the page rather than estimated.
The full research page for ALRTF, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.
Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.